CNCE insider filings
CONCERT PHARMACEUTICALS, INC. — 50 most recent insider filings (SEC Forms 3/4/5) from EDGAR, normalized by FilingPulse. Latest filing: 2023-03-06. Screen CNCE transaction legs live →
Insider transaction summary — last 90 days
No insider filings (Forms 3/4/5) for CNCE between 2026-08-23 and 2026-11-21. The table below lists the most recent filings on record.
Recent insider filings — CONCERT PHARMACEUTICALS, INC.
| Filed | Form | Insider | Reported transactions | Source |
|---|---|---|---|---|
| 2023-03-06 | 4 | van Heek Christi — Director | Code (U): 25,651 · Disposition to issuer (D): 16,400 · Disposition to issuer (D): 25,000 (derivative) · Disposition to issuer (D): 10,000 (derivative) · Disposition to issuer (D): 10,000 (derivative) · Disposition to issuer (D): 10,000 (derivative) · +3 more | EDGAR |
| 2023-03-06 | 4 | Tung Roger D — Chief Executive Officer, Director | Code (U): 756,427 · Disposition to issuer (D): 57,916 · Code (U): 121,873 · Code (U): 13,274 · Code (U): 12,389 · Disposition to issuer (D): 156,675 (derivative) · +7 more | EDGAR |
| 2023-03-06 | 4 | Stuart Nancy — Chief Operating Officer | Code (U): 167,963 · Disposition to issuer (D): 73,233 · Disposition to issuer (D): 21,400 (derivative) · Disposition to issuer (D): 100,000 (derivative) · Disposition to issuer (D): 80,000 (derivative) · Disposition to issuer (D): 70,000 (derivative) · +4 more | EDGAR |
| 2023-03-06 | 4 | Munsie Jeffrey A — Chief Legal Officer | Code (U): 38,350 · Disposition to issuer (D): 49,699 · Disposition to issuer (D): 100,000 (derivative) · Disposition to issuer (D): 42,430 (derivative) · Disposition to issuer (D): 51,850 (derivative) | EDGAR |
| 2023-03-06 | 4 | Hoeiland Jesper — Director | Code (U): 5,125 · Disposition to issuer (D): 16,400 · Disposition to issuer (D): 25,000 (derivative) · Disposition to issuer (D): 10,000 (derivative) · Disposition to issuer (D): 10,250 (derivative) | EDGAR |
| 2023-03-06 | 4 | Becker Marc A. — Chief Financial Officer | Code (U): 56,264 · Disposition to issuer (D): 49,699 · Disposition to issuer (D): 17,900 (derivative) · Disposition to issuer (D): 100,000 (derivative) · Disposition to issuer (D): 110,000 (derivative) · Disposition to issuer (D): 42,430 (derivative) · +1 more | EDGAR |
| 2023-03-06 | 4 | Auchincloss Thomas G — Director | Code (U): 17,625 · Disposition to issuer (D): 16,400 · Disposition to issuer (D): 25,000 (derivative) · Disposition to issuer (D): 10,000 (derivative) · Disposition to issuer (D): 10,000 (derivative) · Disposition to issuer (D): 10,000 (derivative) · +4 more | EDGAR |
| 2023-03-06 | 4 | Cassella James V — Chief Development Officer | Code (U): 80,595 · Disposition to issuer (D): 57,766 · Disposition to issuer (D): 34,700 (derivative) · Disposition to issuer (D): 140,000 (derivative) · Disposition to issuer (D): 50,000 (derivative) · Disposition to issuer (D): 70,000 (derivative) · +4 more | EDGAR |
| 2023-03-06 | 4 | JAEGER WILFRED E — Director | Code (U): 5,125 · Disposition to issuer (D): 16,400 · Disposition to issuer (D): 10,000 (derivative) · Disposition to issuer (D): 10,000 (derivative) · Disposition to issuer (D): 10,000 (derivative) · Disposition to issuer (D): 10,000 (derivative) · +3 more | EDGAR |
| 2023-03-06 | 4 | ALDRICH RICHARD — Director | Code (U): 342,100 · Disposition to issuer (D): 16,400 · Code (U): 210,526 · Code (U): 44,351 · Disposition to issuer (D): 10,000 (derivative) · Disposition to issuer (D): 10,000 (derivative) · +6 more | EDGAR |
| 2023-03-06 | 4 | HUTT PETER BARTON — Director | Code (U): 13,088 · Disposition to issuer (D): 16,400 · Disposition to issuer (D): 10,000 (derivative) · Disposition to issuer (D): 10,000 (derivative) · Disposition to issuer (D): 10,000 (derivative) · Disposition to issuer (D): 10,000 (derivative) · +3 more | EDGAR |
| 2023-02-16 | 4 | Stuart Nancy — Chief Operating Officer | Sale (S): 6,048 @ $8.33 | EDGAR |
| 2023-02-16 | 4 | Munsie Jeffrey A — Chief Legal Officer | Sale (S): 3,762 @ $8.34 | EDGAR |
| 2023-02-16 | 4 | Becker Marc A. — Chief Financial Officer | Sale (S): 3,762 @ $8.33 | EDGAR |
| 2023-02-16 | 4 | Cassella James V — Chief Development Officer | Sale (S): 3,762 @ $8.34 | EDGAR |
| 2023-01-31 | 4 | Stuart Nancy — Chief Operating Officer | Sale (S): 13,200 @ $8.35 | EDGAR |
| 2023-01-31 | 4 | Munsie Jeffrey A — Chief Legal Officer | Sale (S): 8,493 @ $8.35 | EDGAR |
| 2023-01-31 | 4 | Becker Marc A. — Chief Financial Officer | Sale (S): 8,493 @ $8.35 | EDGAR |
| 2023-01-31 | 4 | Cassella James V — Chief Development Officer | Sale (S): 10,106 @ $8.35 | EDGAR |
| 2023-01-09 | 4 | Tung Roger D — Chief Executive Officer, Director | Sale (S): 9,240 @ $7.24 | EDGAR |
| 2023-01-09 | 4 | Stuart Nancy — Chief Operating Officer | Sale (S): 2,893 @ $7.25 | EDGAR |
| 2023-01-09 | 4 | Munsie Jeffrey A — Chief Legal Officer | Sale (S): 2,893 @ $7.25 | EDGAR |
| 2023-01-09 | 4 | Becker Marc A. — Chief Financial Officer | Sale (S): 2,893 @ $7.25 | EDGAR |
| 2023-01-09 | 4 | Cassella James V — Chief Development Officer | Sale (S): 2,893 @ $7.25 | EDGAR |
| 2022-10-18 | 4 | HUTT PETER BARTON — Director | Option exercise (M): 3,539 @ $2.88 · Sale (S): 3,539 @ $6.09 · Option exercise (M): 3,539 (derivative) @ $0 | EDGAR |
| 2022-06-13 | 4 | van Heek Christi — Director | Grant/award (A): 16,400 · Grant/award (A): 7,003 (derivative) @ $0 | EDGAR |
| 2022-06-13 | 4 | Hoeiland Jesper — Director | Grant/award (A): 16,400 | EDGAR |
| 2022-06-13 | 4 | Auchincloss Thomas G — Director | Grant/award (A): 16,400 | EDGAR |
| 2022-06-13 | 4 | JAEGER WILFRED E — Director | Grant/award (A): 16,400 | EDGAR |
| 2022-06-13 | 4 | ALDRICH RICHARD — Director | Grant/award (A): 16,400 · Grant/award (A): 22,410 (derivative) @ $0 | EDGAR |
| 2022-06-13 | 4 | HUTT PETER BARTON — Director | Grant/award (A): 16,400 | EDGAR |
| 2022-06-06 | 4 | van Heek Christi — Director | Purchase (P): 10,526 @ $4.75 | EDGAR |
| 2022-06-06 | 4 | Auchincloss Thomas G — Director | Purchase (P): 6,000 @ $4.75 | EDGAR |
| 2022-06-06 | 4 | ALDRICH RICHARD — Director | Purchase (P): 210,526 @ $4.75 | EDGAR |
| 2022-02-16 | 4 | Tung Roger D — Chief Executive Officer, Director | Sale (S): 13,480 @ $3.09 | EDGAR |
| 2022-02-16 | 4 | Stuart Nancy — Chief Operating Officer | Sale (S): 6,049 @ $3.08 | EDGAR |
| 2022-02-16 | 4 | Munsie Jeffrey A — Chief Legal Officer | Sale (S): 3,762 @ $3.09 | EDGAR |
| 2022-02-16 | 4 | Becker Marc A. — Chief Financial Officer | Sale (S): 3,762 @ $3.08 | EDGAR |
| 2022-02-16 | 4 | Cassella James V — Chief Development Officer | Sale (S): 3,762 @ $3.09 | EDGAR |
| 2022-02-01 | 4 | Tung Roger D — Chief Executive Officer, Director | Grant/award (A): 52,225 · Grant/award (A): 156,675 | EDGAR |
| 2022-02-01 | 4 | Stuart Nancy — Chief Operating Officer | Grant/award (A): 99,000 · Grant/award (A): 21,400 | EDGAR |
| 2022-02-01 | 4 | Munsie Jeffrey A — Chief Legal Officer | Grant/award (A): 63,700 | EDGAR |
| 2022-02-01 | 4 | Becker Marc A. — Chief Financial Officer | Grant/award (A): 63,700 · Grant/award (A): 17,900 | EDGAR |
| 2022-02-01 | 4 | Cassella James V — Chief Development Officer | Grant/award (A): 75,800 · Grant/award (A): 34,700 | EDGAR |
| 2022-01-07 | 4 | Tung Roger D — Chief Executive Officer, Director | Gift (G): 7,000 @ $0 · Gift (G): 7,500 @ $0 · Sale (S): 9,240 @ $3.09 | EDGAR |
| 2022-01-07 | 4 | Stuart Nancy — Chief Operating Officer | Sale (S): 2,894 @ $3.19 | EDGAR |
| 2022-01-07 | 4 | Munsie Jeffrey A — Chief Legal Officer | Sale (S): 2,894 @ $3.20 | EDGAR |
| 2022-01-07 | 4 | Becker Marc A. — Chief Financial Officer | Sale (S): 2,894 @ $3.20 | EDGAR |
| 2022-01-07 | 4 | Cassella James V — Chief Development Officer | Sale (S): 2,894 @ $3.19 | EDGAR |
| 2021-12-15 | 4 | Tung Roger D — Chief Executive Officer, Director | Option exercise (M): 6,700 @ $3.50 · Sale (S): 6,700 @ $3.62 · Option exercise (M): 6,700 (derivative) @ $0 | EDGAR |
Recent 8-K events — CONCERT PHARMACEUTICALS, INC.
Items classified from EDGAR index headers. Browse recent 8-K filings market-wide, by item code →
| Filed | Form | Items reported | Source |
|---|---|---|---|
| 2023-03-06 | 8-K | 2.01 — Completion of Acquisition or Disposition of Assets 3.01 — Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing 3.03 — Material Modification to Rights of Security Holders 5.01 — Changes in Control of Registrant 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers 5.03 — Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year 9.01 — Financial Statements and Exhibits | EDGAR |
| 2023-01-19 | 8-K | 1.01 — Entry into a Material Definitive Agreement 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2022-11-07 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2022-08-22 | 8-K | 8.01 — Other Events | EDGAR |
| 2022-08-04 | 8-K | 2.02 — Results of Operations and Financial Condition 8.01 — Other Events | EDGAR |
| 2022-06-13 | 8-K | 5.07 — Submission of Matters to a Vote of Security Holders 8.01 — Other Events | EDGAR |
| 2022-06-03 | 8-K | 1.01 — Entry into a Material Definitive Agreement 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2022-05-23 | 8-K | 7.01 — Regulation FD Disclosure 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2022-05-12 | 8-K | 8.01 — Other Events | EDGAR |
| 2022-05-05 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?ticker=CNCE returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. Get a free API key → · API docs